IS7111A - Lyfjablanda sem felur í sér róteindadæluhemil og sýrubindandi efni - Google Patents

Lyfjablanda sem felur í sér róteindadæluhemil og sýrubindandi efni

Info

Publication number: IS7111A
Authority: IS; Iceland
Prior art keywords: antacid; pharmaceutical composition; proton pump; pump inhibitor; inhibitor
Prior art date: 2001-07-16

Application number

IS7111A

Other languages

English (en)

Inventor

Criere Bruno

Nouri Nourredine

Pilbrant Åke

Suplie Pascal

Zuccarelli Jean-Marc

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-16

Filing date

2004-01-15

Publication date

2004-01-15

2004-01-15 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2004-01-15 Publication of IS7111A publication Critical patent/IS7111A/is

Links

VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical class [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 title 1
229940069428 antacid Drugs 0.000 title 1
239000003159 antacid agent Substances 0.000 title 1
230000001458 anti-acid effect Effects 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
229940126409 proton pump inhibitor Drugs 0.000 title 1
239000000612 proton pump inhibitor Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Inorganic Chemistry (AREA)
Zoology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

IS7111A 2001-07-16 2004-01-15 Lyfjablanda sem felur í sér róteindadæluhemil og sýrubindandi efni IS7111A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP01401896		2001-07-16
PCT/SE2002/001370 WO2003007917A1 (en)	2001-07-16	2002-07-10	Pharmaceutical formulation comprising a proton pump inhibitor and antacids

Publications (1)

Publication Number	Publication Date
IS7111A true IS7111A (is)	2004-01-15

Family

ID=8182807

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7111A IS7111A (is)	2001-07-16	2004-01-15	Lyfjablanda sem felur í sér róteindadæluhemil og sýrubindandi efni

Country Status (24)

Country	Link
US (2)	US20040219211A1 (is)
EP (1)	EP1416922A1 (is)
JP (1)	JP2004536855A (is)
KR (1)	KR20040018463A (is)
CN (1)	CN100469366C (is)
AR (1)	AR034757A1 (is)
AU (1)	AU2002316020B2 (is)
BG (1)	BG108515A (is)
BR (1)	BR0211117A (is)
CA (1)	CA2453290A1 (is)
CO (1)	CO5550417A2 (is)
HU (1)	HUP0401941A3 (is)
IL (1)	IL159584A0 (is)
IS (1)	IS7111A (is)
MX (1)	MXPA04000385A (is)
MY (1)	MY136137A (is)
NO (1)	NO20040178L (is)
NZ (1)	NZ530511A (is)
PL (1)	PL367686A1 (is)
RU (1)	RU2301662C2 (is)
UA (1)	UA75673C2 (is)
UY (1)	UY27385A1 (is)
WO (1)	WO2003007917A1 (is)
ZA (1)	ZA200400285B (is)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA04002973A (es)	2001-09-28	2005-06-20	Johnson & Johnson	Formas de dosis de liberacion modificada.
DE10304403A1 (de)	2003-01-28	2004-08-05	Röhm GmbH & Co. KG	Verfahren zur Herstellung einer oralen Arzneiform mit unmittelbarem Zerfall und Wirkstofffreisetzung
AR045068A1 (es) *	2003-07-23	2005-10-12	Univ Missouri	Formulacion de liberacion inmediata de composiciones farmaceuticas
TWI372066B (en)	2003-10-01	2012-09-11	Wyeth Corp	Pantoprazole multiparticulate formulations
US8349361B2 (en)	2003-10-15	2013-01-08	Fuji Chemical Industry Co., Ltd.	Composition for rapid disintegrating tablet in oral cavity
JP3841804B2 (ja)	2003-10-15	2006-11-08	富士化学工業株式会社	口腔内速崩壊性錠剤用の組成物
CN100438914C (zh) *	2003-10-15	2008-12-03	富士化学工业株式会社	用于口腔内快速崩解的片剂的组合物
WO2005044223A1 (en) *	2003-11-07	2005-05-19	Takeda Pharmaceutical Company Limited	Chewable tablet
US20050281876A1 (en)	2004-06-18	2005-12-22	Shun-Por Li	Solid dosage form for acid-labile active ingredient
EP1621187A1 (en) *	2004-07-26	2006-02-01	AstraZeneca AB	Pharmaceutical multiparticulate tablet formulations and process for their preparation
US8057820B2 (en)	2004-10-08	2011-11-15	Mcneil-Ppc, Inc.	Enteric coated aspirin granules comingled with binder
US8758814B2 (en)	2004-10-08	2014-06-24	Mcneil-Ppc, Inc.	Chewable enteric coated aspirin tablets
US8673352B2 (en)	2005-04-15	2014-03-18	Mcneil-Ppc, Inc.	Modified release dosage form
DE102005024614A1 (de) *	2005-05-25	2006-11-30	Röhm Gmbh	Verwendung von Polymermischungen zur Herstellung von überzogenen Arzneiformen sowie Arzneiform mit polymerem Mischüberzug
US20080166407A1 (en) *	2005-07-29	2008-07-10	Shalaby Shalaby W	Solid oral formulations for combination therapy
CN100431526C (zh) *	2005-11-07	2008-11-12	上海艾力斯医药科技有限公司	一种酸敏感型药物的快速崩解片剂
CN101120930B (zh) *	2006-08-11	2010-09-29	石药集团中奇制药技术（石家庄）有限公司	一种奥美拉唑组合物及其制备方法
ES2715274T3 (es)	2008-01-10	2019-06-03	Evonik Roehm Gmbh	Preparación farmacéutica o nutracéutica recubierta con liberación de sustancias activas mejorada
CA2711475A1 (en) *	2008-01-10	2009-07-16	Evonik Roehm Gmbh	Coated pharmaceutical or nutraceutical preparation with accelerated controlled active substance release
RU2497503C9 (ru) *	2008-03-10	2014-09-20	Байер Конзюмер Кер АГ	Приятная на вкус твердая композиция, включающая нейтрализатор кислотности и стимулятор слюноотделения
EP2254556A2 (en)	2008-03-11	2010-12-01	Takeda Pharmaceutical Company Limited	Orally-disintegrating solid preparation
US9101565B2 (en) *	2008-11-17	2015-08-11	Takeda Nycomed As	Dissolution stability of calcium carbonate tablets
US20130243859A1 (en) *	2010-12-03	2013-09-19	Takeda Pharmaceutical Company Limited	Orally disintegrating tablet
CN102085188B (zh) *	2011-01-14	2013-01-02	寿光富康制药有限公司	一种兰索拉唑肠溶微丸的制备方法
CN102078616A (zh) *	2011-01-28	2011-06-01	北京虹湾医药技术有限公司	埃索美拉唑碳酸氢钠组合物
US8277842B1 (en) *	2012-01-20	2012-10-02	Dart Neuroscience (Cayman) Ltd.	Enteric-coated HT-2157 compositions and methods of their use
CN102631327B (zh) *	2012-05-14	2013-08-28	海南葫芦娃制药有限公司	一种奥美拉唑肠溶微丸及其制备方法
CN103479593B (zh) *	2013-05-10	2014-10-08	青岛双鲸药业有限公司	一种奥美拉唑肠溶片的制备方法
JP6156037B2 (ja) *	2013-10-03	2017-07-05	ライオン株式会社	固形医薬製剤組成物
CN103784414B (zh) *	2013-12-18	2018-01-30	北京华禧联合科技发展有限公司	一种埃索美拉唑肠溶片及其制备方法
CA2910865C (en)	2014-07-15	2016-11-29	Isa Odidi	Compositions and methods for reducing overdose
US20170042806A1 (en)	2015-04-29	2017-02-16	Dexcel Pharma Technologies Ltd.	Orally disintegrating compositions
JP7156945B2 (ja) *	2016-02-03	2022-10-19	ノバルティスアーゲー	有機化合物のガレヌス製剤
WO2017185123A1 (en) *	2016-04-29	2017-11-02	Alan Thompson	Veterinary composition
US10076494B2 (en)	2016-06-16	2018-09-18	Dexcel Pharma Technologies Ltd.	Stable orally disintegrating pharmaceutical compositions
CN108434117A (zh) *	2018-03-29	2018-08-24	成都通德药业有限公司	一种奥美拉唑肠溶胶囊的制备方法
RU2727506C1 (ru) *	2019-09-09	2020-07-22	Пивипи Лабс Пте. Лтд.	Средство для лечения эректильной дисфункции
KR102531045B1 (ko) *	2020-01-23	2023-05-11	한미약품 주식회사	프로톤 펌프 저해제 및 제산제를 포함하는 약제학적 복합제제
KR20220065997A (ko) *	2020-11-13	2022-05-23	(주)휴온스	라베프라졸 및 제산제를 포함하는 약제학적 복합제제 및 이의 제조방법
IL303390A (en)	2020-12-03	2023-08-01	Battelle Memorial Institute	Compositions of polymer nanoparticles and DNA nanostructures and methods for non-viral transport
CN114617852B (zh) *	2020-12-10	2023-06-27	昆药集团股份有限公司	一种奥美拉唑肠溶制剂及其制备方法
WO2022216977A1 (en)	2021-04-07	2022-10-13	Batelle Memorial Institute	Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
IL312564A (en)	2021-11-05	2024-07-01	Cinclus Pharma Holding Ab Publ	Polymorphs of the hydrochloride salt of linfarezan glurate
WO2025072751A1 (en)	2023-09-29	2025-04-03	Battelle Memorial Institute	Polymer nanoparticle compositions for in vivo expression of polypeptides
AU2024393766A1 (en)	2023-12-08	2026-06-18	Battelle Memorial Institute	Use of dna origami nanostructures for molecular information based data storage systems

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2516408B2 (ja) *	1988-08-18	1996-07-24	エスエス製薬株式会社	被覆顆粒を含む錠剤
DE4122217C2 (de) *	1991-07-04	1997-02-13	Merz & Co Gmbh & Co	Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
US5464632C1 (en) *	1991-07-22	2001-02-20	Prographarm Lab	Rapidly disintegratable multiparticular tablet
DK1078628T3 (da) *	1994-07-08	2009-02-23	Astrazeneca Ab	Tabletteret flerenhedsdoseringsform
SE9600071D0 (sv) *	1996-01-08	1996-01-08	Astra Ab	New oral formulation of two active ingredients I
DE19617487A1 (de) *	1996-05-02	1997-11-06	Merck Patent Gmbh	Geschmacksverbesserung von Arzneimittelwirkstoffen
JP3961596B2 (ja) *	1996-10-15	2007-08-22	富士化学工業株式会社	無機制酸剤含有速分散性造粒物、その製造方法及び用時懸濁内服制酸剤
US6024981A (en) *	1997-04-16	2000-02-15	Cima Labs Inc.	Rapidly dissolving robust dosage form
IL133080A0 (en) *	1997-07-01	2001-03-19	Pfizer	Sertraline salts and sustained-release dosage forms of sertraline
FR2766089B1 (fr) *	1997-07-21	2000-06-02	Prographarm Lab	Comprime multiparticulaire perfectionne a delitement rapide
PT1121103E (pt) *	1998-05-18	2007-02-28	Takeda Pharmaceutical	Comprimidos de desintegração oral compreendendo um benzimidazole
CA2374760A1 (en) *	1999-06-18	2000-12-28	Takeda Chemical Industries, Ltd.	Quickly disintegrating solid preparations
DE19954653B4 (de) *	1999-11-13	2006-01-19	Contitech Profile Gmbh	Extruder zur Aufbereitung von Kautschukmischungen
US6656492B2 (en) *	2000-06-30	2003-12-02	Yamanouchi Pharmaceutical Co., Ltd.	Quick disintegrating tablet in buccal cavity and manufacturing method thereof
US6749867B2 (en) *	2000-11-29	2004-06-15	Joseph R. Robinson	Delivery system for omeprazole and its salts
WO2002045694A1 (en) *	2000-12-07	2002-06-13	Altana Pharma Ag	Rapidly disintegrating tablet comprising an acid-labile active ingredient

2002
- 2002-07-10 EP EP02746288A patent/EP1416922A1/en not_active Withdrawn
- 2002-07-10 AU AU2002316020A patent/AU2002316020B2/en not_active Ceased
- 2002-07-10 PL PL02367686A patent/PL367686A1/xx not_active Application Discontinuation
- 2002-07-10 CA CA002453290A patent/CA2453290A1/en not_active Abandoned
- 2002-07-10 US US10/484,064 patent/US20040219211A1/en not_active Abandoned
- 2002-07-10 IL IL15958402A patent/IL159584A0/xx unknown
- 2002-07-10 NZ NZ530511A patent/NZ530511A/en unknown
- 2002-07-10 MX MXPA04000385A patent/MXPA04000385A/es active IP Right Grant
- 2002-07-10 BR BR0211117-9A patent/BR0211117A/pt not_active IP Right Cessation
- 2002-07-10 WO PCT/SE2002/001370 patent/WO2003007917A1/en not_active Ceased
- 2002-07-10 RU RU2004101061/15A patent/RU2301662C2/ru not_active IP Right Cessation
- 2002-07-10 KR KR10-2004-7000606A patent/KR20040018463A/ko not_active Ceased
- 2002-07-10 AR ARP020102572A patent/AR034757A1/es unknown
- 2002-07-10 JP JP2003513526A patent/JP2004536855A/ja active Pending
- 2002-07-10 HU HU0401941A patent/HUP0401941A3/hu unknown
- 2002-07-10 CN CNB028180135A patent/CN100469366C/zh not_active Expired - Fee Related
- 2002-07-15 MY MYPI20022672A patent/MY136137A/en unknown
- 2002-07-16 UY UY27385A patent/UY27385A1/es unknown
- 2002-10-07 UA UA2004010288A patent/UA75673C2/uk unknown
2004
- 2004-01-06 BG BG108515A patent/BG108515A/xx unknown
- 2004-01-14 ZA ZA2004/00285A patent/ZA200400285B/en unknown
- 2004-01-15 IS IS7111A patent/IS7111A/is unknown
- 2004-01-15 NO NO20040178A patent/NO20040178L/no not_active Application Discontinuation
- 2004-01-16 CO CO04002774A patent/CO5550417A2/es not_active Application Discontinuation
2010
- 2010-06-10 US US12/813,018 patent/US20110135722A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CO5550417A2 (es)	2005-08-31
MXPA04000385A (es)	2004-05-04
NZ530511A (en)	2005-06-24
HUP0401941A2 (hu)	2005-01-28
JP2004536855A (ja)	2004-12-09
AU2002316020B2 (en)	2007-03-15
BG108515A (en)	2005-02-28
IL159584A0 (en)	2004-06-01
CN100469366C (zh)	2009-03-18
HUP0401941A3 (en)	2008-04-28
EP1416922A1 (en)	2004-05-12
NO20040178L (no)	2004-03-16
WO2003007917A1 (en)	2003-01-30
PL367686A1 (en)	2005-03-07
CN1555256A (zh)	2004-12-15
ZA200400285B (en)	2005-06-29
MY136137A (en)	2008-08-29
RU2301662C2 (ru)	2007-06-27
US20110135722A1 (en)	2011-06-09
UA75673C2 (en)	2006-05-15
KR20040018463A (ko)	2004-03-03
UY27385A1 (es)	2003-02-28
US20040219211A1 (en)	2004-11-04
RU2004101061A (ru)	2005-04-20
AR034757A1 (es)	2004-03-17
BR0211117A (pt)	2004-06-22
CA2453290A1 (en)	2003-01-30

Publication	Publication Date	Title
IL159584A0 (en)	2004-06-01	Pharmaceutical formulation comprising a proton pump inhibitor and antacids
IS2716B (is)	2011-02-15	Lyfjaform til inntöku sem samanstendur af prótónpumpuhemli og sýrubindandi lyfi eða algínati
IS2529B (is)	2009-07-15	Nýjar spírótrísýklískar afleiður og notkun þeirra sem fosfódíesterasa-7-hindrar
AU2001296908A1 (en)	2002-04-08	Proton pump inhibitor formulation
IS7434A (is)	2004-09-02	N-amínóasetýl-pýrrólídín-2-karbónítríl og notkun þeirra sem DDP-IV tálma
DK1156806T3 (da)	2004-08-02	Farmaceutisk sammensætning indeholdende protonpumpeinhibitor
PT1188927E (pt)	2005-01-31	Compressores scroll
IS7792A (is)	2005-04-11	Hýdantóínafleiður og notkun þeirra sem TACE hemla
IS2946B (is)	2016-05-15	Lyfjablanda sem felur í sér andrógen
PT1461039E (pt)	2014-12-12	Composições farmacêuticas compreendendo cilostazol e um inibidor da captação de adenosina
NO20024528L (no)	2002-11-19	Proteaseinhibitor, farmasoytisk sammensetning og anvendelse av forbindelsen
HUP0400328A3 (en)	2007-05-29	Metalloproteinase inhibitor azoles and pharmaceutical compositions containing them
DE60027761D1 (de)	2006-06-08	Komprimierte zubereitung enthaltend nichtsteroidale entzündungshemmer
IL205407A0 (en)	2011-07-31	Hyaluronic acid antagonist and inhibitor compositions and uses thereof
IS8181A (is)	2005-12-14	Efnablanda sem felur í sér PDE4 tálma og PDE5 tálma
IS7177A (is)	2004-03-11	Valdekoxíb samsetningar sem leysast upp í munni
DE60143864D1 (de)	2011-03-03	Positive chemisch verstärkte Resistzusammensetzung
DK1404357T3 (da)	2010-05-03	Gonadotropin-frigivende hormonantagonist i gel-dannende koncentrationer
AU2002366796A8 (en)	2003-07-09	Methods using proton pump inhibitors
IS6111A (is)	2001-10-19	Lyfjablanda sem felur í sér þrombínhemil með lágan mólmassa og forlyf hans
NO20040316L (no)	2004-03-18	Sugeanker
IS8287A (is)	2006-02-07	Lyfjablanda sem felur í sér levóþýroxínnatríum
PT1439818E (pt)	2005-03-31	Comprimido mastigavel contendo lisina
DE10195667T1 (de)	2003-04-30	Kompressorventilplatte
IS7219A (is)	2004-04-14	Lyfjablanda sem inniheldur (R) -bíkalútamíð